Tag : Challenge of Rare Diseases

Clinical Research, Pharma & Healthcare Financing

Actio Biosciences Raises $66M Series B for Genetics-Driven Therapeutics

Business Wire
by Business Wire0201
Financing co-led by Regeneron Ventures and Deerfield Management will support advancement of lead programs, ABS-1230 and ABS-0871 Phase 1 trial initiation expected in second half...
The Inner CircleHealthcare and Pharmaceutical

Rare Disease Breakthroughs: How Fast-Tracking is Changing the Game

BI Journal
by BI Journal0463
Explore how fast-tracking approvals are driving rare disease breakthroughs, offering faster treatments and new hope for patients worldwide. Table of Contents1. The Challenge of Rare...